Issued: April 2012.
Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis by National Institute for Health and Clinical Excellence. Published by National Institute for Health and Clinical Excellence in 2012. Publication and catalogue information, links to buy online and reader comments.